{"id":"d6f18aad-d167-5ec3-b871-f35e832c17a2","stable_key":"548ab9d6-3a9b-5bed-879c-17d03813b636:b2-met-dld-i12t-fad-retention","predicate":"reduces-cofactor-retention","statement":"Purified human DLD I12T retained about 0.15 FAD per monomer versus approximately one in wild type, with forward and reverse activities of about 8% and 2%.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"2479470f-c4af-503b-bd43-088c96620caf","mechanism_event_label":"This DLD variant poorly retained FAD and had very low catalytic activity.","subject":{"id":"43a5b8b1-fc47-5b93-a1d9-8eabfa81cafb","slug":"dld-i12t","display_name":"Human DLD Ile12Thr","entity_type_key":"protein_state"},"object":{"id":"e2cd7179-f218-54e8-9ce9-7a836ae35fac","slug":"fad","display_name":"FAD","entity_type_key":"small_molecule"},"evidence_count":1,"mechanism_event":{"id":"2479470f-c4af-503b-bd43-088c96620caf","stable_key":"548ab9d6-3a9b-5bed-879c-17d03813b636:b2-met-dld-i12t-fad-retention-event","event_type":"biochemical_relationship","label":"This DLD variant poorly retained FAD and had very low catalytic activity.","description":"Purified human DLD I12T retained about 0.15 FAD per monomer versus approximately one in wild type, with forward and reverse activities of about 8% and 2%.","status":"provisional","compartment":{"slug":"mitochondria","display_name":"Mitochondria"},"participants":[{"entity":{"id":"640b6164-093b-5297-a6bf-55ac8da852ae","slug":"dld","display_name":"DLD","entity_type_key":"protein"},"role":"wild-type shared B1-system enzyme","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"283ed24b-06a1-50aa-9281-df3bac6ce37e","slug":"nad-plus","display_name":"NAD+","entity_type_key":"small_molecule"},"role":"forward reaction cosubstrate","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"b5c4e83d-5757-5e08-9fc9-fa2683c78b43","slug":"protein-bound-dihydrolipoamide","display_name":"Protein-bound reduced dihydrolipoyl-lysine","entity_type_key":"chemical_species"},"role":"physiological substrate class","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"43a5b8b1-fc47-5b93-a1d9-8eabfa81cafb","slug":"dld-i12t","display_name":"Human DLD Ile12Thr","entity_type_key":"protein_state"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"e2cd7179-f218-54e8-9ce9-7a836ae35fac","slug":"fad","display_name":"FAD","entity_type_key":"small_molecule"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"cross_nutrient","value_text":"DLD is reused from the B1 complexes; its flavin/NAD step is distinct from upstream thiamine diphosphate chemistry.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_spans","value_text":"[{\"source_bundle\": \"artifacts/riboflavin_metabolism_sources.json\", \"source_key\": \"PMC10341545\", \"locator\": \"XML .//body//p\", \"paragraph_index\": 19, \"char_start\": 0, \"char_end\": 871, \"evidence_access\": \"full-text\"}]","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Recombinant human DLD variants expressed in E. coli BL21(DE3), FAD quantification, activity, chromatography and crystallography.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"I12T mutagenesis, purified-protein FAD and activity assays.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Purification instability can affect measured occupancy; correlation does not prove FAD loss alone caused all activity loss.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Riboflavin research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"riboflavin","display_name":"Riboflavin (vitamin B2)","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Homo sapiens","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"This DLD variant poorly retained FAD and had very low catalytic activity.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[szabo-2023-dld-variants] Structural and Biochemical Investigation of Selected Pathogenic Mutants of the Human Dihydrolipoamide Dehydrogenase (2023). https://pubmed.ncbi.nlm.nih.gov/37446004/ DOI: 10.3390/ijms241310826","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Recombinant DLD expressed in E. coli","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"e85b8355-adb8-5bc0-b48c-95eeef1d8d99","evidence_kind":"source_excerpt","locator":"Lines 847-859","start_line":847,"end_line":859,"excerpt":"### b2-met-dld-i12t-fad-retention\nPurified human DLD I12T retained about 0.15 FAD per monomer versus approximately one in wild type, with forward and reverse activities of about 8% and 2%.\nCondition category: machinery_impairment\nnutrient_topic: Riboflavin research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: This DLD variant poorly retained FAD and had very low catalytic activity.\norganism: Homo sapiens\ntissue_or_cell_type: Recombinant DLD expressed in E. coli\nexperimental_model: Recombinant human DLD variants expressed in E. coli BL21(DE3), FAD quantification, activity, chromatography and crystallography.\nlimitations: Purification instability can affect measured occupancy; correlation does not prove FAD loss alone caused all activity loss.\nexposure: I12T mutagenesis, purified-protein FAD and activity assays.\ncross_nutrient: DLD is reused from the B1 complexes; its flavin/NAD step is distinct from upstream thiamine diphosphate chemistry.\nevidence_spans: [{\"source_bundle\": \"artifacts/riboflavin_metabolism_sources.json\", \"source_key\": \"PMC10341545\", \"locator\": \"XML .//body//p\", \"paragraph_index\": 19, \"char_start\": 0, \"char_end\": 871, \"evidence_access\": \"full-text\"}]\n[szabo-2023-dld-variants] Structural and Biochemical Investigation of Selected Pathogenic Mutants of the Human Dihydrolipoamide Dehydrogenase (2023). https://pubmed.ncbi.nlm.nih.gov/37446004/ DOI: 10.3390/ijms241310826","model_system":"Recombinant human DLD variants expressed in E. coli BL21(DE3), FAD quantification, activity, chromatography and crystallography.","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [szabo-2023-dld-variants] Structural and Biochemical Investigation of Selected Pathogenic Mutants of the Human Dihydrolipoamide Dehydrogenase (2023). https://pubmed.ncbi.nlm.nih.gov/37446004/ DOI: 10.3390/ijms241310826","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"4f7c9578-82bf-5e2d-b5c4-72a79fb4f6af","stable_key":"import-548ab9d6-3a9b-5bed-879c-17d03813b636","title":"Riboflavin: mechanisms, deficiency and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"680cb6bc8249877f2410f551807f10d390fdd719014137d7414ba3420e29228d","revision_id":"7a61e299-908d-5372-860b-99ed190f9d7a","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}